
Background: Digitalization in the health sector has markedly influenced service offerings. This study considers the use of mobile applications as innovative tools for assessment and management. Previous studies indicate that mobile apps can assess pain, gait, posture, balance, range of motion, and neurological function. The main purpose of this scoping review is to examine the integration of mobile apps into physiotherapy assessment, mainly by evaluating their validity and clinical use. Methods: This review conducted a systematic search and found 67 potentially relevant studies. Preliminary screening based on titles and abstracts excluded 33 articles that did not meet the inclusion criteria. The author conducted a thorough full-text evaluation of all remaining 34 articles, finally reviewing 14 high-quality studies from 2014-2024 that satisfied all inclusion criteria. Results: Mobile application-based assessment in physiotherapy facilitates accessibility and individualized patient care, enabling precise outcomes. Previous studies involving athletes, elderly participants, and pediatric populations have validated tools such as accelerometers (used in motion analysis), inclinometry apps, and GPS-integrated walking tests. These tools have been compared with established instruments, such as standard Vicon systems, universal goniometers, and clinical traditional assessment protocols. Conclusion: This research defines the scope of mobile app use and its capacity to transform clinical physiotherapy practices by enhancing personalized, real-time, and accurate evaluation techniques in assessment procedures.
Background: Robot-assisted radical prostatectomy (RARP) is widely used for localized and locally advanced prostate cancer. However, conventional clinicopathologic models provide limited accuracy in predicting postoperative oncologic outcomes. Artificial intelligence (AI) and machine learning (ML) models integrating multiparametric magnetic resonance imaging (MRI) radiomics, genomic classifiers, and clinicopathologic variables may improve individualized risk stratification. The main objective of this study was to systematically review AI-based models incorporating MRI radiomics, genomic signatures, clinicopathologic factors, or surgical variables to predict oncologic outcomes after RARP, and to determine whether operative technique variables have been included. Methods: PubMed, Scopus, and Web of Science were systematically searched. Although the review was not prospectively registered, methodological safeguards were described and applied. Two reviewers independently screened records using predefined eligibility criteria, with disagreements resolved by consensus or third-reviewer adjudication. Six studies were included in the qualitative synthesis. Risk of bias was assessed using the Prediction model Risk of Bias Assessment Tool (PROBAST). Meta-analysis was not performed because of substantial heterogeneity in outcomes, predictors, model architectures, and performance reporting. A descriptive forest-style visualization of the best-reported model discrimination was generated. Results: Of the 296 records identified, 14 duplicates were removed and 282 titles and abstracts were screened. Thirty-one full-text articles were assessed, resulting in 6 studies for the core synthesis and 7 contextual references. Studies were conducted across Europe, Asia, North America, and South America. Predicted outcomes included extraprostatic extension, positive surgical margins, pathological upgrading, early biochemical recurrence, and lymph-node involvement. Best-reported area under the curve (AUC) values ranged from 0.711 for pathological upgrading to 0.970 for positive surgical margins. Three studies used external or independent validation cohorts, while one incorporated a validated genomic classifier. None included intraoperative surgical technique variables as model predictors. Calibration was reported in two studies and decision-curve analysis in three. PROBAST assessment indicated low overall risk of bias in two studies and moderate risk in four. Conclusion: AI-based models show promise for predicting oncologic outcomes after RARP, but current evidence remains heterogeneous and incompletely validated. The absence of operative technique variables represents an important and underrecognized evidence gap. Multimodal data integration, standardized reporting, external validation, and prospective evaluation are required before routine clinical implementation.
Background: Chronic hyperglycemia and oxidative stress lead to chronic, slow-healing wounds; this can result in diabetic foot ulcers (DFUs), which affect 6.3% of the diabetic population and lead to limb amputation in approximately 30% of cases. Because of their complex healing processes, including impaired angiogenesis and dysfunctional fibroblasts, a system of assessing granulation in DFUs is essential, especially in low-resource countries. Innovations in artificial intelligence have created models to automate the process of segregating wounds and to help quantify the amount of tissue. This review focuses on the assessment of DFU granulation using deep learning models and the barriers to and challenges in clinical application and implementation. Methods: This systematic review followed PRISMA 2020 guidelines and was registered in Open Science Framework Registries (https://osf.io/rkpv8). PubMed, ScienceDirect, Scopus, and IEEE Xplore were searched for studies published between January 2015 and March 2025 evaluating deep learning or computer vision models for DFU granulation tissue segmentation or classification. Three reviewers independently performed screening, data extraction, and quality assessment using an adapted QUADAS-2 framework covering dataset selection, index test, reference standard, and validation strategy. Out of 766 identified records, 16 studies meeting the quantitative eligibility criteria were included. Due to substantial methodological heterogeneity, a narrative synthesis was performed instead of a meta-analysis. Results: Sixteen studies were included. All studies reported using at least one public or private dataset and at least one Diabetic Foot Ulcers Grand Challenge (DFUC) 2022 dataset. The most common frameworks were U-Net and its derivatives ( n = 7), followed by standard convolutional neural networks (CNNs), EfficientNet models, and hybrid CNN-transformer models. The researchers reported Dice similarity coefficient (DSC) values between 0.88 and 0.94 and IoU values between 0.82 and 0.91. All area under the curve (AUC) values, which range between 0 and 1 and where values closer to 1 indicate better performance, were greater than 0.85, thus indicating good performance. The highest segmentation performance was achieved with optimized EfficientNet-B3, DeepLab V3+, DoubleU-Net, and transformer models. Image quality, expert annotations, preprocessing, and validation approached performance in a systematic manner. Most of the studies reported a low bias risk; however, there were concerns about the study datasets and the external validation. Conclusion: Models based on U-Nets, when coupled with ResNets, EfficientNets, and transformers, demonstrate high precision in diagnosing the granulation level of DFUs and can have significant positive effects on digital wound care and telemedicine. However, their lack of multicenter validation and retrospective, single-center designs currently limits the clinical application. To be able to use these models in daily clinical DFU management, large prospective multicenter studies must be conducted.
Magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) has emerged as a powerful noninvasive therapy with expanding applications in oncology, neurology, and beyond. Reliable preclinical evaluation relies on tissue-mimicking phantoms (TMPs), which provide controlled platforms for assessing the acoustic, thermal, and imaging performance of MRgHIFU protocols and related equipment. This review employs a narrative methodology to integrate representative findings from the field, drawing on PubMed and Google Scholar searches using keyword combinations related to MRgHIFU, phantom development, and associated research areas. The reviewed literature highlights the main principles and materials underlying HIFU phantom design, their application in evaluating MRgHIFU physics and their role in preclinical and clinical quality assurance (QA) of magnetic resonance imaging (MRI)-compatible robotic systems—including assessments of targeting accuracy and thermal delivery reliability—as well as their integration with MR thermometry. The analysis also identifies ongoing challenges and future directions, emphasizing the value of phantom-based studies that support greater reliability and translatability in MRgHIFU research. TMPs provide an indispensable basis for QA and controlled MRgHIFU assessment, yet improved physiological realism is needed to enhance suitability for thermal-response assessment and translatability, and further standardization is required to ensure consistency across studies.